Joshua M. Eizen - Sep 29, 2022 Form 3 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Signature
/s/ Lucy Day, Attorney-in-Fact for Joshua M. Eizen
Stock symbol
ANTX
Transactions as of
Sep 29, 2022
Transactions value $
$0
Form type
3
Date filed
10/5/2022, 06:21 PM
Next filing
Oct 28, 2022

No securities are beneficially owned.

Remarks:

General Counsel, Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney